基本信息
浏览量:149
职业迁徙
个人简介
Ammar A. Javed, MD is the lead postdoctoral research fellow, database manager and program coordinator for clinical, translational and molecular research for the Division of Surgical Oncology (Pancreatic Surgery), Department of Surgery at the Johns Hopkins School of Medicine. As an avid researcher, he is involved in both clinical and translational research in the field of pancreatic surgery and pancreatic cancer biology.
His research revolves around improving our understanding of the biology of pancreatic cancer aimed at improving both diagnostic techniques and therapeutics currently being used to treat this lethal disease. Under the mentorship of Dr. Christopher Wolfgang, Dr. Jin He, and Dr. Richard Burkhart Dr. Javed and his colleagues are currently developing novel techniques to isolate and characterize circulating tumor cells in the peripheral blood of patients, as well as techniques to establish tumor-derived organoid. Their goal is to identify subtypes of pancreatic cancer and correlate these findings to the clinicopathological features such as treatment response and long-term outcomes of these patients. Furthermore, with the use of drug-sensitivity testing on tumor-derived organoids they aim to pave a path for precision medicine approaches to patient care in the near future.
On the clinical side, his research focuses on the identification of factors associated with long term outcomes of patients undergoing resection of malignant diseases as well as those associated with increased risk of postoperative complications and higher healthcare costs in patients undergoing pancreatic surgery for all indications. In addition to numerous retrospective studies, he has been responsible for multiple randomized control trials evaluating interventions that can help alleviate the burden of postoperative morbidity and decrease the associated healthcare costs.
His research revolves around improving our understanding of the biology of pancreatic cancer aimed at improving both diagnostic techniques and therapeutics currently being used to treat this lethal disease. Under the mentorship of Dr. Christopher Wolfgang, Dr. Jin He, and Dr. Richard Burkhart Dr. Javed and his colleagues are currently developing novel techniques to isolate and characterize circulating tumor cells in the peripheral blood of patients, as well as techniques to establish tumor-derived organoid. Their goal is to identify subtypes of pancreatic cancer and correlate these findings to the clinicopathological features such as treatment response and long-term outcomes of these patients. Furthermore, with the use of drug-sensitivity testing on tumor-derived organoids they aim to pave a path for precision medicine approaches to patient care in the near future.
On the clinical side, his research focuses on the identification of factors associated with long term outcomes of patients undergoing resection of malignant diseases as well as those associated with increased risk of postoperative complications and higher healthcare costs in patients undergoing pancreatic surgery for all indications. In addition to numerous retrospective studies, he has been responsible for multiple randomized control trials evaluating interventions that can help alleviate the burden of postoperative morbidity and decrease the associated healthcare costs.
研究兴趣
论文作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
作者统计
#Papers: 210
#Citation: 6770
H-Index: 34
G-Index: 81
Sociability: 7
Diversity: 3
Activity: 66
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn